Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

NCT04746547 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Hiv

Interventions

DRUG: Dolutegravir 50 MG
DRUG: Dolutegravir 10 MG

Sponsor

University of KwaZulu

Collaborators

[object Object]